AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy

Clinical Trial Summary

A prospective, single-arm, non-blinded study, intending to treat and collect and evaluate data in up to ten (10) human subjects who are currently being treated with hemodialysis and who present with acute thrombosis in their arteriovenous (AV) grafts, treated with the CAPERE® Thrombectomy System.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05071872` - PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft
	Completed	`NCT03839264` - Optimal Screening Program in Detecting Stenosis and Predicting Thrombosis in Hemodialysis Graft

See also

Status

Clinical Trial

Phase

Completed

NCT05071872 - PMCF of Rotarex®S & Aspirex®S Catheters in Treating Thrombotic Occlusion of Arteriovenous Graft

Completed

NCT03839264 - Optimal Screening Program in Detecting Stenosis and Predicting Thrombosis in Hemodialysis Graft

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04494035
Study type	Interventional
Source	Medtronic Endovascular
Contact
Status	Terminated
Phase	N/A
Start date	January 14, 2020
Completion date	October 23, 2020

AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System — AVATR

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms